535 related articles for article (PubMed ID: 23616586)
21. Narcolepsy with cataplexy.
Dauvilliers Y; Arnulf I; Mignot E
Lancet; 2007 Feb; 369(9560):499-511. PubMed ID: 17292770
[TBL] [Abstract][Full Text] [Related]
22. Sleepiness that cannot be overcome: narcolepsy and cataplexy.
Han F
Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619
[TBL] [Abstract][Full Text] [Related]
23. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model.
Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR
Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540
[TBL] [Abstract][Full Text] [Related]
24. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep.
Roman A; Meftah S; Arthaud S; Luppi PH; Peyron C
Sleep; 2018 Jun; 41(6):. PubMed ID: 29522212
[TBL] [Abstract][Full Text] [Related]
25. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
[TBL] [Abstract][Full Text] [Related]
26. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
Takahashi K; Lin JS; Sakai K
Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
[TBL] [Abstract][Full Text] [Related]
27. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
[TBL] [Abstract][Full Text] [Related]
28. Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin.
Mäkelä KA; Wigren HK; Zant JC; Sakurai T; Alhonen L; Kostin A; Porkka-Heiskanen T; Herzig KH
Acta Physiol (Oxf); 2010 Mar; 198(3):237-49. PubMed ID: 20003098
[TBL] [Abstract][Full Text] [Related]
29. Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy.
Seifinejad A; Li S; Possovre ML; Vassalli A; Tafti M
Nat Commun; 2020 Nov; 11(1):6034. PubMed ID: 33247179
[TBL] [Abstract][Full Text] [Related]
30. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
31. Orexin gene transfer into the amygdala suppresses both spontaneous and emotion-induced cataplexy in orexin-knockout mice.
Liu M; Blanco-Centurion C; Konadhode RR; Luan L; Shiromani PJ
Eur J Neurosci; 2016 Mar; 43(5):681-8. PubMed ID: 26741960
[TBL] [Abstract][Full Text] [Related]
32. The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice.
Sun Y; Tisdale R; Park S; Ma SC; Heu J; Haire M; Allocca G; Yamanaka A; Morairty SR; Kilduff TS
Sleep; 2022 Dec; 45(12):. PubMed ID: 35182424
[TBL] [Abstract][Full Text] [Related]
33. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy.
Kaushik MK; Aritake K; Imanishi A; Kanbayashi T; Ichikawa T; Shimizu T; Urade Y; Yanagisawa M
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):6046-6051. PubMed ID: 29784823
[TBL] [Abstract][Full Text] [Related]
34. Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy.
Schwartz S; Ponz A; Poryazova R; Werth E; Boesiger P; Khatami R; Bassetti CL
Brain; 2008 Feb; 131(Pt 2):514-22. PubMed ID: 18094020
[TBL] [Abstract][Full Text] [Related]
35. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
[TBL] [Abstract][Full Text] [Related]
36. Narcolepsy: pathophysiology and pharmacology.
Nishino S
J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
[TBL] [Abstract][Full Text] [Related]
37. The spectrum of REM sleep-related episodes in children with type 1 narcolepsy.
Antelmi E; Pizza F; Vandi S; Neccia G; Ferri R; Bruni O; Filardi M; Cantalupo G; Liguori R; Plazzi G
Brain; 2017 Jun; 140(6):1669-1679. PubMed ID: 28472332
[TBL] [Abstract][Full Text] [Related]
38. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.
Tabuchi S; Tsunematsu T; Black SW; Tominaga M; Maruyama M; Takagi K; Minokoshi Y; Sakurai T; Kilduff TS; Yamanaka A
J Neurosci; 2014 May; 34(19):6495-509. PubMed ID: 24806676
[TBL] [Abstract][Full Text] [Related]
39. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy.
Liblau RS; Vassalli A; Seifinejad A; Tafti M
Lancet Neurol; 2015 Mar; 14(3):318-28. PubMed ID: 25728441
[TBL] [Abstract][Full Text] [Related]
40. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
